Search Results

Pressure BioSciences, Inc. announced they are actively pursuing and evaluating multiple artificial intelligence and machine learning prospective partnerships.

Pressure BioSciences, Inc. reported that Company scientists collaborating with scientists from Lonza Biologics presented convincing evidence that the Company’s patented BaroFoldTM high-pressure protein disaggregation and refolding process provides significant advantages in cost, efficiency, and environmental impact remediation over current methods widely employed in biomanufacturing protein drugs, a market expected to reach $488 billion by 2030.

Pressure BioSciences, Inc. announced a key transition in its collaborations with multiple leaders and innovators in global biopharmaceutical development and commercialization, including preeminent Contract Development and Manufacturing Organizations.

Pressure BioSciences, Inc., a leader in the development and sale of innovative, broadly enabling, high pressure-based instruments, platform technologies, and related consumables for the worldwide life sciences, agriculture, food & beverage, and other key industries, announced the strategic expansion of its patented BaroFold technology platform, with continued growth in services, sales and leasing.